1. Introduction/Overview Antiplatelet drugs constitute a cornerstone of pharmacotherapy for the prevention and treatment of arterial thrombotic events. These agents function by inhibiting platelet activation, adhesion, or aggregation, thereby impeding the formation of occlusive thrombi within the vasculature. The clinical significance of these drugs is substantial, given the global burden of atherosclerotic cardiovascular diseases, including … Read more
Introduction/Overview The management of dyslipidemia represents a cornerstone in the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). Hypolipidemic drugs, also termed lipid-lowering agents, comprise a diverse group of pharmacological interventions designed to modify circulating plasma lipid and lipoprotein concentrations. The clinical imperative for these agents stems from the established causal relationship between elevated levels … Read more
1. Introduction/Overview Dyslipidemia represents a major modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD), a leading cause of global morbidity and mortality. The pharmacological management of dyslipidemia, primarily through the use of hypolipidemic drugs, constitutes a cornerstone of preventive cardiology. These agents target various components of lipid metabolism to reduce circulating levels of atherogenic lipoproteins, … Read more
Introduction/Overview Antiarrhythmic drugs constitute a critical therapeutic class designed to suppress or prevent abnormal cardiac rhythms, known as arrhythmias. These disorders of cardiac impulse formation or conduction can range from benign palpitations to life-threatening ventricular tachyarrhythmias, contributing significantly to global cardiovascular morbidity and mortality. The fundamental goal of antiarrhythmic pharmacotherapy is to restore and maintain … Read more
Introduction/Overview Cardiac arrhythmias represent a diverse group of disorders characterized by abnormal electrical activity in the heart, leading to disturbances in rate, rhythm, or sequence of cardiac depolarization. The pharmacological management of these conditions constitutes a critical component of cardiovascular therapeutics. Antiarrhythmic drugs are employed to suppress or prevent arrhythmias, thereby alleviating symptoms, improving hemodynamic … Read more
1. Introduction/Overview Myocardial infarction (MI), commonly known as a heart attack, represents a critical medical emergency characterized by the irreversible necrosis of cardiac myocytes secondary to prolonged ischemia. This event is most frequently precipitated by the acute thrombotic occlusion of a coronary artery, typically arising from the rupture or erosion of an atherosclerotic plaque. The … Read more
1. Introduction/Overview The pharmacological induction of vasodilation represents a cornerstone therapeutic strategy in the management of numerous cardiovascular and non-cardiovascular disorders. Vasodilators are a heterogeneous group of agents that act through diverse mechanisms to reduce vascular smooth muscle tone, leading to an increase in the caliber of blood vessels. This reduction in peripheral vascular resistance, … Read more
1. Introduction/Overview Calcium channel blockers (CCBs) represent a major class of cardiovascular drugs that inhibit the transmembrane influx of calcium ions through voltage-gated L-type calcium channels. The therapeutic utility of these agents is predicated on their ability to modulate calcium-dependent physiological processes, particularly within the cardiovascular system. Since their introduction in the 1960s, CCBs have … Read more
1. Introduction/Overview The renin-angiotensin-aldosterone system (RAAS) constitutes a critical hormonal cascade that regulates blood pressure, fluid volume, and electrolyte balance. Its dysregulation is implicated in the pathophysiology of several major cardiovascular and renal diseases, including hypertension, heart failure, chronic kidney disease, and diabetic nephropathy. Consequently, pharmacological agents designed to modulate this system represent a cornerstone … Read more
Introduction/Overview The pharmacology of drugs of abuse represents a critical intersection of neurobiology, pharmacokinetics, and clinical medicine. Substance use disorders constitute a major public health burden, characterized by a compulsive pattern of drug-seeking and use despite significant harmful consequences. Understanding the pharmacological principles underlying these agents is essential for healthcare professionals to manage intoxication, withdrawal, … Read more